ExThera Medical Publishes Results of ‘CRE Superbug’ Binding Study: A Device-based Therapy for Drug-resistant Bacterial ...

ExThera Medical Corporation, a pioneer in the development of broad-spectrum, dialysis-like therapeutic devices to treat life-threatening bloodstream infections, disclosed today that its Seraph® Microbind® Affinity Blood Filter removed 99.9% of two Carbapenem-Resistant Enterobacteriaceae — E.



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1tSlzy4

via IFTTT